Myovant Sciences Ltd (MYOV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 09-2016 | 06-2016 | 03-2016 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 73 | N/A | N/A |
| TOTAL | $111 | $N/A | $N/A |
| Non-Current Assets | |||
| PPE Net | 110 | N/A | N/A |
| Other Non-Current Assets | 1,774 | 524 | 0 |
| TOTAL | $1,884 | $524 | $N/A |
| Total Assets | $1,995 | $524 | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 4,838 | 1,153 | 0 |
| Accrued Expenses | 2,526 | 990 | N/A |
| TOTAL | $7,365 | $2,147 | $N/A |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 32,555 | 6,975 | 0 |
| TOTAL | $32,555 | $6,975 | $N/A |
| Total Liabilities | $39,920 | $9,122 | $N/A |
| Shareholders' Equity | |||
| Shares Outstanding, K | 60,249 | 60,228 | N/A |
| Common Shares | 2 | 1 | N/A |
| Retained earnings | -55,340 | -20,627 | N/A |
| Other shareholders' equity | -2 | -1 | 0 |
| TOTAL | $-37,925 | $-8,598 | $N/A |
| Total Liabilities And Equity | $1,995 | $524 | $0 |